"International Agencies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
International organizations which provide health-related or other cooperative services.
| Descriptor ID |
D007390
|
| MeSH Number(s) |
N03.540.514
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "International Agencies".
Below are MeSH descriptors whose meaning is more specific than "International Agencies".
This graph shows the total number of publications written about "International Agencies" by people in this website by year, and whether "International Agencies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 2 | 2 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "International Agencies" by people in Profiles.
-
Prospective Evaluation of Multinational Association of Supportive Care in Cancer Risk Index Score for Gynecologic Oncology Patients With Febrile Neutropenia. Am J Clin Oncol. 2019 02; 42(2):138-142.
-
Failing States as Epidemiologic Risk Zones: Implications for Global Health Security. Health Secur. 2017 May/Jun; 15(3):288-295.
-
The IASLC/ITMIG thymic malignancies staging project: development of a stage classification for thymic malignancies. J Thorac Oncol. 2013 Dec; 8(12):1467-73.
-
Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS). Blood. 2013 May 30; 121(22):4457-62.
-
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012 Aug; 64(8):2677-86.
-
Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation. J Hepatol. 2011 Apr; 54(4):695-704.
-
Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer. J Clin Oncol. 2009 Apr 20; 27(12):1941-7.
-
Permanent Committee of the International Congress of Human Genetics. Am J Med Genet. 1998 Sep 01; 79(2):79-81.